BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 1370521)

  • 1. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses.
    Bronze MS; Courtney HS; Dale JB
    J Immunol; 1992 Feb; 148(3):888-93. PubMed ID: 1370521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant tetravalent group A streptococcal M protein vaccine.
    Dale JB; Chiang EY; Lederer JW
    J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain.
    Bronze MS; Dale JB
    J Immunol; 1993 Sep; 151(5):2820-8. PubMed ID: 7689617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
    Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF
    J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
    Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
    Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic peptide fragments of streptococcal M proteins.
    Seyer JM; Dale JB; Beachey EH
    Dev Biol Stand; 1986; 63():101-8. PubMed ID: 2427375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin.
    Vashishtha A; Fischetti VA
    J Immunol; 1993 May; 150(10):4693-701. PubMed ID: 8482854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
    Olive C; Ho MF; Dyer J; Lincoln D; Barozzi N; Toth I; Good MF
    J Infect Dis; 2006 Jun; 193(12):1666-76. PubMed ID: 16703510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies.
    Pruksakorn S; Galbraith A; Houghten RA; Good MF
    J Immunol; 1992 Oct; 149(8):2729-35. PubMed ID: 1383324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping a conserved conformational epitope from the M protein of group A streptococci.
    Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
    Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence of protective epitopes of streptococcal M proteins shared with cardiac sarcolemmal membranes.
    Sargent SJ; Beachey EH; Corbett CE; Dale JB
    J Immunol; 1987 Aug; 139(4):1285-90. PubMed ID: 2440952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein.
    Beachey EH; Seyer JM
    J Immunol; 1986 Mar; 136(6):2287-92. PubMed ID: 2419429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
    Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
    BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.
    Kraus W; Haanes-Fritz E; Cleary PP; Seyer JM; Dale JB; Beachey EH
    J Immunol; 1987 Nov; 139(9):3084-90. PubMed ID: 2444650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium.
    Baird RW; Bronze MS; Kraus W; Hill HR; Veasey LG; Dale JB
    J Immunol; 1991 May; 146(9):3132-7. PubMed ID: 2016540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an epitope of type 1 streptococcal M protein that is shared with a 43-kDa protein of human myocardium and renal glomeruli.
    Kraus W; Dale JB; Beachey EH
    J Immunol; 1990 Dec; 145(12):4089-93. PubMed ID: 1701783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Processing of viable group A streptococci leads to major histocompatibility complex class II presentation of T cell epitopes from the major protective antigen.
    Rossiter BA; Alfonso C; Kehoe MA; Robinson JH
    Eur J Immunol; 1994 May; 24(5):1244-7. PubMed ID: 7514136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein.
    Dale JB; Beachey EH
    J Exp Med; 1986 May; 163(5):1191-202. PubMed ID: 2422314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective immunity evoked by locally administered group A streptococcal vaccines in mice.
    Bronze MS; McKinsey DS; Beachey EH; Dale JB
    J Immunol; 1988 Oct; 141(8):2767-70. PubMed ID: 3049817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.